PT - JOURNAL ARTICLE AU - Hagn, Gerhard AU - Meier-Menches, Samuel M. AU - Plessl-Walder, Günter AU - Mitra, Gaurav AU - Mohr, Thomas AU - Preindl, Karin AU - Schlatter, Andreas AU - Schmidl, Doreen AU - Gerner, Christopher AU - Garhöfer, Gerhard AU - Bileck, Andrea TI - Yes, it matters: in contrast to blood plasma, serum metabolomics is confounded by platelets AID - 10.1101/2023.05.09.23289660 DP - 2023 Jan 01 TA - medRxiv PG - 2023.05.09.23289660 4099 - http://medrxiv.org/content/early/2023/05/11/2023.05.09.23289660.short 4100 - http://medrxiv.org/content/early/2023/05/11/2023.05.09.23289660.full AB - Metabolomics is an emerging and powerful molecular profiling method supporting clinical investigations. For clinical metabolomics studies, serum is commonly used. Serum is collected after blood coagulation, a complex biochemical process involving active platelet metabolism. This may proof relevant as platelet counts and function may vary substantially in individuals. Applying a multi-omics analysis strategy comprising proteins and metabolites with a focus on lipid mediators, we systematically investigated serum and plasma obtained from the same healthy donors. While Biocrates MxP Quant 500 results correlated well (n=461, R2=0.991), lipid mediators (n=77, R2=0.906) and proteins (n=322, R2=0.860) differed substantially between serum and plasma. Actually, secretome analysis of activated platelets identified all proteins and most lipid mediators significantly enriched in serum when compared to plasma. Furthermore, a prospective, randomized, controlled parallel group metabolomics trial was performed, monitored by serum and plasma analyses. Healthy individuals received either acetylsalicylic acid, affecting platelets, or omega-3 fatty acids, hardly affecting platelets, for a period of seven days. In the acetylsalicylic acid group, serum analysis apparently demonstrated a significant drug-induced downregulation of the lipid mediators TXB2 and 12-HETE. The absence of these observation in plasma analyses suggested that these drug effects took place only during blood coagulation. Other effects of acetylsalicylic acid on alpha-linolenic acid and the fatty acid composition of triglycerides were detected both in serum and plasma. In the omega-3 fatty acid group, serum and plasma analysis results did not differ. These data strongly support the hypothesis that the serum metabolome is substantially confounded by platelets.Key pointsSerum metabolomics data are confounded by plateletsClinical evaluation of drug effects should be based on plasma metabolomicsCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05775536Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Ethics Committee of the Medical University of Vienna (EC No.: 2250/2020) and the Austrian competent authorities. The study was conducted in concordance with the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines of the European Union.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll proteomics data was submitted to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) and is available in the PRIDE partner repository with the dataset identifier PXD041781 and PXD041785. Data derived from all metabolomics as well as fatty acid and lipid mediators analyses produced in the present study are available upon request to the authors.